Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

AureoGen Announces Licensing Agreement with Merck

KALAMAZOO, Mich., Feb. 24, 2016 /PRNewswire/ — AureoGen Biosciences Inc. today announced a licensing agreement with Merck, known as MSD outside the United States and Canada, for the use of AureoGen’s proprietary chemistry and compounds for the development of medicines for infectious disease, including systemic fungal infections. Under the agreement, Merck receives exclusive rights to […]

Read More »

Proving Zika guilty: A long and painstaking task

Evidence is building for the theory that Zika can cause newborn brain defects and the World Health Organization is promising more answers in weeks, but nailing a definitive link will be neither simple nor swift. Picking apart numerous potential connections between mothers who show evidence of infection with the mosquito-borne virus and babies born with […]

Read More »

Brexit is the wrong prescription, says European pharma industry

Britain’s departure from the European Union would threaten scientific research and jeopardize the 28-nation bloc’s system of drug regulation, the European pharmaceutical industry said on Wednesday.   The declaration is the clearest statement yet on the issue by an industry that includes EU-based players such as Britain’s GlaxoSmithKline and AstraZeneca, France’s Sanofi and Germany’s Bayer. […]

Read More »

Regen BioPharma, Inc. Completes Preclinical Experimentation for Its siRNA NR2F6 Checkpoint Inhibitor

SAN DIEGO, February 24, 2016 /PRNewswire/ — Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today completion of experiments, in collaboration with Dr. Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach.  Subsequent to these experiments, the Company has begun the process of compiling an Investigational New Drug Application (IND) with […]

Read More »

Otsuka Announces Worldwide Access Plan for Delamanid with Stop TB Partnership’s Global Drug Facility

MUNICH, February 24, 2016 /PRNewswire/ — Recognizing the immediate need for access to new therapeutic options for multidrug-resistant TB (MDR-TB), Otsuka Novel Products GmbH (Otsuka) today announced an ambitious new public-private partnership with the Stop TB Partnership (Stop TB) to increase access and scale-up treatment of delamanid (Deltyba™) in low- and middle-income countries. Any country […]

Read More »

Nine Cancer Centers Accuse Genentech of Shipping Less Herceptin than Promised

Nine cancer care centers in seven states claim in a flurry of lawsuits that Genentech Inc. shipped less of its popular breast cancer-fighting drug Herceptin than labeled. The suits, filed in New York, Texas, Florida, Virginia, Tennessee, Minnesota and Oklahoma, say vials of freeze-dried Herceptin when mixed with a liquid failed to produce the correct […]

Read More »

For Clinical Trials, Centralized Imaging Data Collection and Review Is a Must

  By Joseph Pierro, chief medical officer of Biomedical Systems.   In many clinical trials, clinical imaging plays an important role in the drug development process. Whether the trial involves drugs, biologics, or devices, imaging may be used to measure the efficacy and safety of the investigational product. An independent assessment based on the centralized […]

Read More »

Career Conversation on Inclusive Leadership

Registration is now open for Career Conversation 10 – Inclusive LeadershipMarch 1 – 12:00 PM ET – Webinar   What does it mean to be an inclusive leader, and why is inclusiveness important? What are the potential business benefits associated with an inclusive work environment or leadership style? And how can business professionals develop/strengthen their […]

Read More »

New Jersey Rare Disease Alliance Commemorates Global Rare Disease Day

Hosts February 29 Event on Building Relationships and Raising Awareness   Ramsey, NJ (February 19, 2016)  The New Jersey Rare Disease Alliance – dedicated to improving the lives of the more than 800,000 rare disease patients in New Jersey – is hosting an event on Monday, February 29 to observe global Rare Disease Day, at […]

Read More »

Greater Good Receives Registered Nonprofit Status To Partner With Global Clients, Local Charities

New York, NY (February 23, 2016) – Greater Good, the nonprofit subsidiary of The Greater Than One Group, has been designated a 501(c)(3) organization, allowing it to expand its nonprofit activities for charitable purposes. “Now with 501(c)(3) status, Greater Good can grow its efforts to help provide sustainable and impactful programs for people around the […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!


Ad Right Bottom